IQVIA Holdings (IQV) Stock Analysis & AI Equity Report

Medical - Pharmaceuticals USD Explore free reports

IQVIA Holdings (IQV) overview

IQVIA Holdings (IQV) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 16,310m and operating profit of USD 2,182m; the year-end share price was 225.41 USD and market capitalisation was USD 38,230m. IQVIA Holdings is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get IQVIA Holdings's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 6,503mFY 2025
Share price225.41 USDFY 2025 year end
RevenueUSD 16,310mFY 2025
Operating profitUSD 2,182mFY 2025
Net earningsUSD 1,360mFY 2025
Market capitalisationUSD 38,230mFY 2025 year end

About IQVIA Holdings

IQVIA provides clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare organizations. It combines healthcare data, analytics, technology, and industry expertise in offerings that support clinical trial design, site selection, and patient recruitment, as well as real-world research and commercial operations. Customers include pharmaceutical, biotech, and medical device companies, researchers, government agencies, payers, and other healthcare stakeholders.

Generate the IQVIA Holdings report

IQVIA Holdings is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for IQVIA Holdings and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on IQVIA Holdings

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.